Inventor · disambiguated record
Genliang Lu
Also filed as: LU GENLIANG
28 granted patents·22 pending applications·542 citations·filing 2007–2024
97Inventor score
Files withWAVE LIFE SCIENCES LTD25MOLECULAR INSIGHT PHARM INC11BABICH JOHN W4MADRIGAL PHARMACEUTICALS INC2CUMBRE IP VENTURES L P1
Top patents by PatentIndex Score
50 records- 0197US8211402B2CA-IX specific radiopharmaceuticals for the treatment and imaging of cancerBABICH JOHN W·Filed 2009·Granted Jul 3, 2012·46 cites·33 claims
- 0296US8962799B2Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Feb 24, 2015·75 cites·26 claims
- 0396US8926944B2Radiolabeled prostate specific membrane antigen inhibitorsBABICH JOHN W·Filed 2012·Granted Jan 6, 2015·60 cites·7 claims
- 0496US8840865B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2013·Granted Sep 23, 2014·32 cites·26 claims
- 0596US8211401B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMABABICH JOHN W·Filed 2009·Granted Jul 3, 2012·93 cites·20 claims
- 0695US10450568B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Oct 22, 2019·61 cites·13 claims
- 0795US8562945B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofBABICH JOHN W·Filed 2009·Granted Oct 22, 2013·31 cites·23 claims
- 0894US11013757B2Oligonucleotides, compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2017·Granted May 25, 2021·19 cites·20 claims
- 0993US11603532B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 14, 2023·11 cites·20 claims
- 1093US8877970B2Inhibitors of carbonic anhydrase IXZIMMERMAN CRAIG·Filed 2009·Granted Nov 4, 2014·34 cites·9 claims
- 1192US11739325B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 29, 2023·12 cites·23 claims
- 1291US12428442B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2023·Granted Sep 30, 2025·1 cites·21 claims
- 1391US11718638B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 8, 2023·10 cites·20 claims
- 1491US11597927B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 7, 2023·11 cites·15 claims
- 1590US9433594B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2015·Granted Sep 6, 2016·5 cites·5 claims
- 1689US9447121B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Sep 20, 2016·10 cites·23 claims
- 1788US9120837B2Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IXMOLECULAR INSIGHT PHARM INC·Filed 2013·Granted Sep 1, 2015·5 cites·31 claims
- 1887US9388144B2Radiolabeled prostate specific membrane antigen inhibitorsMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Jul 12, 2016·9 cites·29 claims
- 1986US10086096B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2017·Granted Oct 2, 2018·4 cites·22 claims
- 2083US10201624B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2016·Granted Feb 12, 2019·3 cites·19 claims
- 2178US12391942B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2019·Granted Aug 19, 2025·2 cites·32 claims
- 2278US10898598B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2018·Granted Jan 26, 2021·1 cites·24 claims
- 2378US7678791B2Nitroheteroaryl-containing rifamycin derivativesCUMBRE IP VENTURES L P·Filed 2007·Granted Mar 16, 2010·4 cites·7 claims
- 2478US2024117347A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 2575US2025066775A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 2674US2024109931A1Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 2773US11712485B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2020·Granted Aug 1, 2023·0 cites·20 claims
- 2871US7666864B2Bicyclic nitroimidazole-substituted phenyl oxazolidinonesGLOBAL ALLIANCE FOR TB DRUG DE·Filed 2009·Granted Feb 23, 2010·3 cites·15 claims
- 2970US12403156B2Oligonucleotides, compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2021·Granted Sep 2, 2025·0 cites·7 claims
- 3070US2024132894A1Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 3170US2024175018A1Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
- 3270US2023295617A1Methods and compositions of biologically active agentsWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 3363US2025262235A1Oligonucleotide compositions and methods relating theretoWAVE LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
- 3463US2024026358A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 3562US2025302995A1Oligonucleotide compositions and methods thereofSHIVALILA CHIKDU SHAKTI·Filed 2023·Application pending·0 cites
- 3662US2019390197A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 3759US2023392137A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 3859US2025135036A1Compositions for editing mecp2 transcripts and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 3959US2021198305A1Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2018·Application pending·0 cites
- 4059US2025333740A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 4159US2019127733A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2016·Application pending·0 cites
- 4258US10828315B2Targeted therapeuticsMADRIGAL PHARMACEUTICALS INC·Filed 2016·Granted Nov 10, 2020·0 cites·2 claims
- 4357US2021085700A1Targeted therapeuticsMADRIGAL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4455US9422251B2Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IXMOLECULAR INSIGHT PHARM INC·Filed 2015·Granted Aug 23, 2016·0 cites·9 claims
- 4550US2023329201A1Cells and non-human animals engineered to express adar1 and uses thereofWAVE LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 4649US2023220384A1Oligonucleotide compositions and methods of use thereofMONIAN PRASHANT·Filed 2020·Application pending·0 cites
- 4748US2023203087A1Oligonucleotide compositions and methods thereofKANDASAMY PACHAMUTHU·Filed 2021·Application pending·0 cites
- 4846US2022186217A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2019·Application pending·0 cites
- 4944US2019249173A1Methods and compositions of biologically active agentsVARGEESE CHANDRA·Filed 2017·Application pending·0 cites
- 5037US2017136085A1Targeted therapeuticsSYNTA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Genliang Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →